COVID-19 Disease in Patients With Recurrent Pericarditis During Treatment With Anakinra: Comment on the Article by Navarro-Millán et al.

Negro, Enrica; Trotta, Lucia; Pancrazi, Massimo; Bizzi, Emanuele; Brenna, Martino; Mardigyan, Vartan; Imazio, Massimo; Brucato, Antonio

Negro, Enrica; Trotta, Lucia; Pancrazi, Massimo; Bizzi, Emanuele; Brenna, Martino; Mardigyan, Vartan; Imazio, Massimo; Brucato, Antonio.

Negro E; Fatebenefratelli Hospital, Milan, Italy.
Trotta L; Fatebenefratelli Hospital, Milan, Italy.
Pancrazi M; Fatebenefratelli Hospital, Milan, Italy.
Bizzi E; Fatebenefratelli Hospital, Milan, Italy.
Brenna M; Fatebenefratelli Hospital, Milan, Italy.
Mardigyan V; McGill University and Jewish General Hospital, Montreal, Quebec, Canada.
Imazio M; Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
Brucato A; Università di Milano andFatebenefratelli Hospital, Milan, Italy.

Arthritis Rheumatol ; 73(8): 1562-1563, 2021 08.

Article in English | MEDLINE | ID: covidwho-1332945

Subject(s)

COVID-19; Pericarditis; Humans; Interleukin 1 Receptor Antagonist Protein; Pericarditis/chemically induced; Pericarditis/drug therapy; Recurrence; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pericarditis / COVID-19 Limits: Humans Language: English Journal: Arthritis Rheumatol Year: 2021 Document Type: Article Affiliation country: Art.41702

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google